Esperion Snags $125M Deal With Daiichi On Cholesterol Drug
By Gianna Ferrarin · January 3, 2024, 7:52 PM EST
Esperion Therapeutics Inc. on Wednesday announced a $125 million deal with a Japanese pharmaceutical giant to resolve Esperion's demand for $300 million from the company over Esperion's cholesterol reduction drugs....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login